Sheri L Holmen

18PUBLICATIONS
129CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical mycologySocio-economic developmentToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma.

|Apr 28, 2026
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.

|Mar 27, 2026
Focal adhesion kinase promotes metastasis in BRAF-mutant melanoma.

Karly A Stanley, MiKaela N Field, Adriene M Pavek

|Feb 27, 2026
Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic Directions.

Kayla T O'Toole, Brandon M Roan, Timothy M Hardman

|Oct 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Jennifer M Wiggins, Qiao Zhang, Yian Zhang

|Nov 07, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

Kathleen Conway, Sharon N Edmiston, Amanda Vondras

Pageof 3

Frequent Collaborators

5 joint publications

Martin McMahon

4 joint publications

Matthew W VanBrocklin

4 joint publications

Gennie L Parkman

3 joint publications

Irene Orlow